Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ASLAN Pharmaceuticals Limited (ASLN)

  • Technical Exchange News
  • July 19, 2024, 00:57 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: ASLAN Pharmaceuticals Limited - American Depositary Shares.

Comment Full text

Xenetic Biosciences Inc. (XBIOW)

  • Technical Exchange News
  • July 19, 2024, 00:57 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Xenetic Biosciences, Inc. - Warrants.

Comment Full text

Xenetic Biosciences Inc. (XBIOW)

  • Technical Exchange News
  • July 19, 2024, 00:57 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Xenetic Biosciences, Inc. - Warrants.

Comment Full text

Xenetic Biosciences Inc. (XBIOW)

  • Technical Exchange News
  • July 19, 2024, 00:57 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Xenetic Biosciences, Inc. - Warrants. New value: Xenetic Biosciences, Inc. - Warrants.

Comment Full text

ASLAN Pharmaceuticals Limited (ASLN)

  • Technical Exchange News
  • July 19, 2024, 00:57 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: ASLAN Pharmaceuticals Limited - American Depositary Shares. New value: ASLAN Pharmaceuticals Limited - American Depositary Shares.

Comment Full text

Neuroone Medical Technologies Corp (NMTC)

  • Technical Exchange News
  • July 18, 2024, 18:48 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Gossamer Bio Inc (GOSS)

  • Technical Exchange News
  • July 18, 2024, 18:47 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Gain Therapeutics Inc. (GANX)

  • Technical Exchange News
  • July 18, 2024, 18:47 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Dare Bioscience Inc. (DARE)

  • Technical Exchange News
  • July 18, 2024, 18:47 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bionomics Limited (BNOX)

  • Technical Exchange News
  • July 18, 2024, 18:47 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 625
  • 626
  • 627
  • 628
  • 629
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235876)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143290)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin